| Targeting human cancer by a glycosaminoglycan binding malaria protein A Salanti, TM Clausen, MØ Agerbæk, N Al Nakouzi, M Dahlbäck, HZ Oo, ... Cancer cell 28 (4), 500-514, 2015 | 229 | 2015 |
| Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer Y Wakamatsu, N Sakamoto, HZ Oo, Y Naito, N Uraoka, K Anami, ... Pathology international 62 (2), 112-119, 2012 | 228 | 2012 |
| TEM8/ANTXR1-specific CAR T cells as a targeted therapy for triple-negative breast cancer TT Byrd, K Fousek, A Pignata, C Szot, H Samaha, S Seaman, ... Cancer research 78 (2), 489-500, 2018 | 138 | 2018 |
| Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer M Korpal, X Puyang, Z Jeremy Wu, R Seiler, C Furman, HZ Oo, M Seiler, ... Nature communications 8 (1), 103, 2017 | 129 | 2017 |
| Eradication of B-ALL using chimeric antigen receptor–expressing T cells targeting the TSLPR oncoprotein H Qin, M Cho, W Haso, L Zhang, SK Tasian, HZ Oo, GL Negri, Y Lin, ... Blood, The Journal of the American Society of Hematology 126 (5), 629-639, 2015 | 129 | 2015 |
| BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma R Shrestha, N Nabavi, YY Lin, F Mo, S Anderson, S Volik, HH Adomat, ... Genome medicine 11, 1-12, 2019 | 103 | 2019 |
| Micro RNA‐148a is downregulated in gastric cancer, targets MMP 7, and indicates tumor invasiveness and poor prognosis N Sakamoto, Y Naito, N Oue, K Sentani, N Uraoka, HZ Oo, K Yanagihara, ... Cancer science 105 (2), 236-243, 2014 | 100 | 2014 |
| Divergent biological response to neoadjuvant chemotherapy in muscle-invasive bladder cancer R Seiler, EA Gibb, NQ Wang, HZ Oo, HM Lam, KE Van Kessel, ... Clinical cancer research 25 (16), 5082-5093, 2019 | 98 | 2019 |
| Not all NOTCH is created equal: the oncogenic role of NOTCH2 in bladder cancer and its implications for targeted therapy T Hayashi, KM Gust, AW Wyatt, A Goriki, W Jäger, S Awrey, N Li, HZ Oo, ... Clinical Cancer Research 22 (12), 2981-2992, 2016 | 88 | 2016 |
| Molecular characterization of neuroendocrine-like bladder cancer J Batista da Costa, EA Gibb, TJ Bivalacqua, Y Liu, HZ Oo, DT Miyamoto, ... Clinical cancer research 25 (13), 3908-3920, 2019 | 85 | 2019 |
| Targeting HER2 with T-DM1, an antibody cytotoxic drug conjugate, is effective in HER2 over expressing bladder cancer T Hayashi, R Seiler, HZ Oo, W Jäger, I Moskalev, S Awrey, T Dejima, ... The Journal of urology 194 (4), 1120-1131, 2015 | 82 | 2015 |
| Oncofetal chondroitin sulfate glycosaminoglycans are key players in integrin signaling and tumor cell motility TM Clausen, MA Pereira, N Al Nakouzi, HZ Oo, MØ Agerbæk, S Lee, ... Molecular Cancer Research 14 (12), 1288-1299, 2016 | 67 | 2016 |
| Cancer cells employ nuclear caspase-8 to overcome the p53-dependent G2/M checkpoint through cleavage of USP28 I Müller, E Strozyk, S Schindler, S Beissert, HZ Oo, T Sauter, P Lucarelli, ... Molecular cell 77 (5), 970-984. e7, 2020 | 64 | 2020 |
| Selective inhibition of the lactate transporter MCT4 reduces growth of invasive bladder cancer T Todenhöfer, R Seiler, C Stewart, I Moskalev, J Gao, S Ladhar, ... Molecular Cancer Therapeutics 17 (12), 2746-2755, 2018 | 64 | 2018 |
| Proteomic screens for suppressors of anoikis identify IL1RAP as a promising surface target in Ewing sarcoma HF Zhang, CS Hughes, W Li, JZ He, D Surdez, AM El-Naggar, H Cheng, ... Cancer discovery 11 (11), 2884-2903, 2021 | 51 | 2021 |
| Androgen-regulated transcription of ESRP2 drives alternative splicing patterns in prostate cancer J Munkley, L Li, SRG Krishnan, G Hysenaj, E Scott, C Dalgliesh, HZ Oo, ... Elife 8, e47678, 2019 | 51 | 2019 |
| An oncofetal glycosaminoglycan modification provides therapeutic access to cisplatin-resistant bladder cancer R Seiler, HZ Oo, D Tortora, TM Clausen, CK Wang, G Kumar, MA Pereira, ... European urology 72 (1), 142-150, 2017 | 48 | 2017 |
| NOT-gated CD93 CAR T cells effectively target AML with minimized endothelial cross-reactivity RM Richards, F Zhao, KA Freitas, KR Parker, P Xu, A Fan, E Sotillo, ... Blood Cancer Discovery 2 (6), 648-665, 2021 | 47 | 2021 |
| Hepatoma-derived growth factor-related protein 2 promotes DNA repair by homologous recombination A Baude, TL Aaes, B Zhai, N Al-Nakouzi, HZ Oo, M Daugaard, M Rohde, ... Nucleic Acids Research 44 (5), 2214-2226, 2016 | 47 | 2016 |
| TSPAN8, identified by Escherichia coli ampicillin secretion trap, is associated with cell growth and invasion in gastric cancer K Anami, N Oue, T Noguchi, N Sakamoto, K Sentani, T Hayashi, Y Naito, ... Gastric Cancer 19, 370-380, 2016 | 42 | 2016 |
